Why is the Incannex share price spiking 8% on Tuesday?

The stock has caught a bid on Tuesday.

| More on:
A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Incannex shares have lifted today following the release of a company presentation
  • In it the company gave an in depth view of its assets and operations, including the value proposition at hand
  • In the last 12 months the Incannex share price has clipped a 5% gain

The Incannex Healthcare Ltd (ASX: IHL) share price has jumped from the opening gate on Tuesday.

At the time of writing, Incannex was trading nearly 8% higher at 28 cents a share following the release of a company presentation.

It's a welcome gain for the medicinal cannabis company which has seen its share price plunge 55% over the past few months.

The chart below shows the Incannex share price plotted against the S&P/ASX 200 Index (ASX: XJO) for the past 12 months of trading.

TradingView Chart

What did Incannex release?

The company posted an overview of its assets, operations, and unique value proposition in the presentation released today.

Incannex described its intellectual property's "six categories of opportunity".

The company said it covers a potential $290 billion addressable market estimate for its lead drug candidates and $2 billion per year in potential revenue from psychedelic treatment therapies.

One of Incannex's lead drug candidates is IHL-42X, indicated in the treatment of obstructive sleep apnoea (OSA).

The OSA devices market is valued at US$10 billion, Incannex said, and it's projected to grow at 6.2% annually.

The drug candidate has made inroads in providing a novel solution to OSA, with data from clinical trials holding up well from a safety and efficacy standpoint.

So much so, the patent application for the drug "was considered 'novel and inventive' by [the] international patent examiner", Incannex said.

Incannex also noted it had a cash position of $37.5 million as of 30 June 2022 after raising $24 million in an equity raising in Mary 2022.

Those shares were issued at 35 cents a piece, a decent notch above the company's current share price.

The Incannex share price has clipped a 4% gain these past 12 months.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors finished the trading week on a high note this Friday.

Read more »

Happy teen friends jumping in front of a wall.
Share Gainers

4 ASX 200 shares leading the charge higher this week

Investors have been piling into these four ASX 200 shares this week. But why?

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Share Gainers

Why Catapult, Champion Iron, Healthco, and Meeka Metals shares are pushing higher today

These shares are ending the week on a high. But why?

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors saw another day of mild gains for the stock market this Thursday.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

These shares are having a good session today. But why are investors buying them?

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors panicked when the latest inflation figures came out today.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Mac Copper, Pro Medicus, Web Travel, and Yancoal shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a pleasant Tuesday session for ASX investors today.

Read more »